Sie suchten nach: puberty (Englisch - Maltesisch)

treatment should not be started near the onset of puberty.
kura m’ għandhiex tinbeda qrib il- bidu tal- pubertà.

induced heat is not observed if treatment is started before puberty.
saħna indotta ma ġietx osservata jekk it-trattament jingħata qabel l-puberta.

it is therefore not recommended to initiate treatment near onset of puberty.
għalhekk, mhux rakkomandat li tibda l-kura qrib il-bidu tal-pubertà.

experience in initiating treatment in sga patients near onset of puberty is limited.
l-esperjenza fil-bidu tal-kura f’pazjenti b’sga li jkunu qrib il-bidu tal-pubertà hi limitata.

treatment should not be used in children who have almost stopped growing after puberty.
il-kura m’għandhiex tintuża fi tfal li jkunu kważi waqfu jikbru wara l-pubertà.

treatment of juvenile rats for 30 day beginning at 21 days of age delayed the puberty onset.
il-kura ta’ firien żgħar għal 30 ġurnata minn meta kellhom 21 jum ittardjat il-bidu tal-pubertà.

- experience in starting treatment in sga patients near the onset of puberty is limited.
- l- esperjenza fil- bidu tal- kura f’ pazjenti b’ sga qrib il- bidu tal- pubertà hi limitata.

long-term effects of losartan on growth, puberty and general development have not been studied.
effetti fit- tul ta ’ losartan fuq it- tkabbir, il- pubertà u l- iżvilupp ġenerali ma ġewx studjati.

busulfan treatment in a pre-adolescent girl prevented the onset of puberty due to ovarian failure.
it-trattament bil-busulfan f’tifla preadoloxxenti fixkel il-bidu tal-pubertà minħabba l-falliment ovarjan.

if you notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor.
jekk tinnota li it-tifel/tifla tiegħek qed tikber iżjed bil-mod jew tara żvilupp tal-pubertà mhux mistenni, jekk jogħoġbok kellem lit-tabib tiegħek.

busilvex can also produce symptoms of menopause and in pre-adolescent girls it can prevent the onset of puberty.
busilvex jista ’ ukoll jipproduċi sintomi ta ’ menopawsa u fil- każ ta ’ bniet ta ’ qabel l- adolexxenza, jista 'jitwaqqaf il- bidu tal- pubertà.

busulfan fresenius kabi can also produce symptoms of menopause and in pre-adolescent girls it can prevent the onset of puberty.
busulfan fresenius kabi jista 'wkoll jipproduċi sintomi ta’ menopawża u f’tfajliet pre-adolexxenti jista’ jipprevjenji l-bidu tal-pubertà.

for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty.
għal użu bħala alternattiva għal kastrazzjoni fiżika għal tnaqqis fir-riħa / togħma avversa assoċjati mal-faħal u kkawżat minn adrostenone, sustanza prinċipali fir-riħa / togħma avversa assoċjati mal- faħal, fi ħnieżer irġiel mhux imsewwija kif jidħlu għal pubertà.

however, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.
madanakollu, mhumiex magħrufa l-effetti fit-tul fuq it-tagħlim, l-intelliġenza, il-kobor, il-funzjoni endokrinali, il- puberta’ u l-potenzjal li wieħed ikollu t-tfal.

he/ she may decide if your dose should be adjusted. • no impact on growth and puberty were noticed in children who have taken keppra.
dan/ din jista 'jiddeċiedi li jbidillek id- doża. • ma deherx li kien hemm xi effett fuq il- kobor u l- puberta` fit- tfal li ħadu keppra.

boar taint is an offensive smell or taste in pork or pork products derived from non-castrated male pigs (boars) that have reached puberty.
ir- riħa sesswali tal-faħal hija riħa jew togħma ħażina fil-majjal jew fil-prodotti tal-majjal miksubin minn ħnieżer irġiel mhux imsewwija (faħal) li jkunu laħqu l-pubertà.

repeated intravenous administration of defibrotide, at doses below and close to the human therapeutic dose, to juvenile rats resulted in a delay in the mean age of preputial separation, suggesting a delay in the onset of male puberty in rats.
għoti ġol-vini ripetut ta' defibrotide, f'dożi inqas u qrib id-doża terapewtika umana, għal firien ġuvenili rriżulta f'dewmien fl-età medja tas-separazzjoni preputjali, u dan jissuġġerixxi dewmien fil- bidu tal-pubertà maskili fil-firien.

the long-term effects of ivabradine on growth, puberty and general development as well as the long- term efficacy of therapy with ivabradine in childhood to reduce cardiovascular morbidity and mortality have not been studied.
l-effetti fit-tul ta’ ivabradine fuq it-tkabbir, il-pubertà u l-iżvilupp ġenerali kif ukoll l-effikaċja fit-tul tat-terapija b’ivabradine fit-tfulija biex titnaqqas il-morbidità u l-mortalità kardjovaskulari ma ġewx studjati.

the daily insulin requirement may be higher in patients with insulin resistance (e. g. during puberty or due to obesity) and lower in patients with residual, endogenous insulin production.
il- ħtieġa ta 'l- insulina ta' kuljum tista 'tkun ogħla f' pazjenti b' reżistenza għall- insulina (eż. waqt il- pubertà jew minħabba obeżità), u aktar baxxa f' pazjenti bi produzzjoni residwa ta' insulina endoġenika.

following a single administration, return to ovarian activity after implant removal may take longer in bitches treated before puberty (average 255 days, range 36-429 days) than in adult bitches (average 68 days, range 12 to 264 days).
wara amministrazzjoni waħda, l-ovarji jistgħu jdumu aktar ma jiġu attivi wara li jitneħħa l-impjant f’kelbiet trattati qabel il-puberta (medja 255 ġranet, perjodu bejn 36-429 ġranet) milli kelbat adulti (medja 68 ġranet, perjodu bejn 12 - 264 ġranet).